A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL and Blast Phase CML in Adults
Marlise R. Luskin,Mark Alan Murakami, Julia Keating,Eric S. Winer,Jacqueline S. Garcia,Maximilian Stahl,Martha Wadleigh,Yael Flamand,Donna S. Neuberg,Ilene Galinsky,Rebecca Leonard,Ella Hagopian, Chase M Weizer, Carlin McLanahan,Richard M Stone,Eunice S. Wang,Wendy Stock,Daniel J. DeAngelo Blood（2023）
AI 理解论文
溯源树
样例
